This year, a joint BTS-UKEMS Congress will be held at Robinson College, Cambridge, from 15th – 17th April 2019.

IGG will host a session on Monday 15th April:

Symposium 4: New paradigms of genotoxicity safety evaluation for risk assessment

Chairs: Dr Julia Kenny (GSK) & Dr Patricia Parris (AstraZeneca)

16:45 – 17:15  Bob Young (Merck, Bioreliance Testing Services)

Use of Duplex Sequencing™ for Detection of In Vivo Mutagenesis and early Preneoplastic Events as Biomarkers of Human Cancer Risk (sponsored by Merck)

17:15 – 17:45 Dr Stefan Pfuhler (P&G)

Newly Validated 3D Skin Genotoxicity Assays Improve Safety Assessments of Cosmetic Ingredients

17:45 – 18:15 Dr Giel Hendriks (Toxys)

Novel extensions of the ToxTracker genotoxicity assay to provide insight into mode of action of aneugenic and clastogenic chemicals

18:15 – 18:30 Ms Rebekah Beck (University of Manchester)

Genome-wide and gene-specific methylation assays to identify potential associations between de-methylating compounds and genotoxicity.

Download the Meeting Flyer here.

Visit the meeting website here